Chilton Capital Management »

Corbus Pharmaceuticals Hldgs shares owned by Chilton Capital Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Chilton Capital Management from 13F filings

Historical chart of Chilton Capital Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Chilton Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Chilton Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $273 29 9.41

More positions owned by Chilton Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Ventas (VTR)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Quanta Services (PWR)
Advanced Micro Devices (AMD)
Thermo Fisher Scientific (TMO)
Dover Corporation (DOV)
Gilead Sciences (GILD)

View all positions for Chilton Capital Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
BlackRock
Standard Life Aberdeen
Diadema Partners
Vanguard Capital Management
Jones Hill Capital
Prosight Management
Caption Management
Susquehanna International
ADAR1 Capital Management
Stonepine Capital Management
Geode Capital Management
Citadel Advisors
Dimensional Fund Advisors

View all funds holding Corbus Pharmaceuticals Hldgs